Viewing Study NCT01672450


Ignite Creation Date: 2025-12-24 @ 5:10 PM
Ignite Modification Date: 2025-12-26 @ 10:00 AM
Study NCT ID: NCT01672450
Status: COMPLETED
Last Update Posted: 2015-07-08
First Post: 2012-08-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Intratumoral Injection of Interleukin-2 and Ipilimumab in Patients With Unresectable Stages III-IV Melanoma
Sponsor: University of Utah
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module